These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 9353423)
21. Cytokines and suppressor macrophages cause tumor-bearing host CD8+ T cells to suppress recognition of allogeneic and syngeneic MHC class II molecules. Walker TM; Yurochko AD; Burger CJ; Elgert KD J Leukoc Biol; 1992 Dec; 52(6):661-9. PubMed ID: 1464737 [TBL] [Abstract][Full Text] [Related]
22. Epothilone B stabilizes microtubuli of macrophages like taxol without showing taxol-like endotoxin activity. Muhlradt PF; Sasse F Cancer Res; 1997 Aug; 57(16):3344-6. PubMed ID: 9269992 [TBL] [Abstract][Full Text] [Related]
23. Modulation of alloreactivity by Mac-1+, -2+, and -3+ macrophages from normal and tumor-bearing hosts: flow cytofluorometrically separated macrophages. Askew D; Burger CJ; Elgert KD Immunobiology; 1990 Dec; 182(1):1-10. PubMed ID: 2151512 [TBL] [Abstract][Full Text] [Related]
24. Tumor growth changes the contribution of granulocyte-macrophage colony-stimulating factor during macrophage-mediated suppression of allorecognition. Walker TM; Yurochko AD; Burger CJ; Elgert KD Immunobiology; 1992 Sep; 185(5):427-39. PubMed ID: 1452214 [TBL] [Abstract][Full Text] [Related]
25. CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages. Kirikae F; Kirikae T; Qureshi N; Takayama K; Morrison DC; Nakano M Infect Immun; 1995 Feb; 63(2):486-97. PubMed ID: 7529746 [TBL] [Abstract][Full Text] [Related]
29. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target. Jiang H; Stewart CA; Fast DJ; Leu RW J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576 [TBL] [Abstract][Full Text] [Related]
30. Normal and tumor-bearing host macrophage factor-mediated modulation of mixed-lymphocyte reaction responsiveness: separation of T-lymphocyte subset susceptibility to enhancing and inhibitory factors. Malick AP; Garner RE; Black SP; Elgert KD Cell Immunol; 1984 May; 85(2):549-55. PubMed ID: 6232006 [TBL] [Abstract][Full Text] [Related]
31. Tumor-induced modulation of macrophage class II MHC molecule mRNA expression. Askew D; Burger CJ; Elgert KD Mol Immunol; 1993 Jul; 30(10):911-20. PubMed ID: 8341283 [TBL] [Abstract][Full Text] [Related]
32. Selective suppression of host T cell and macrophage activities during 7,12-dimethylbenz[a]anthracene-induced carcinogenesis. Yamashita U; Hamaoka T Gan; 1982 Oct; 73(5):773-82. PubMed ID: 6219909 [TBL] [Abstract][Full Text] [Related]
34. Tumor-induced alteration in macrophage accessory cell activity on autoreactive T cells. Yurochko AD; Nagarkatti PS; Nagarkatti M; Elgert KD Cancer Immunol Immunother; 1989; 30(3):170-6. PubMed ID: 2598186 [TBL] [Abstract][Full Text] [Related]
35. Entamoeba histolytica modulates the nitric oxide synthase gene and nitric oxide production by macrophages for cytotoxicity against amoebae and tumour cells. Wang W; Keller K; Chadee K Immunology; 1994 Dec; 83(4):601-10. PubMed ID: 7533135 [TBL] [Abstract][Full Text] [Related]
36. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1. Nelson BJ; Ralph P; Green SJ; Nacy CA J Immunol; 1991 Mar; 146(6):1849-57. PubMed ID: 1900875 [TBL] [Abstract][Full Text] [Related]
37. Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages. Elgert KD; Farrar WL J Immunol; 1978 Apr; 120(4):1345-53. PubMed ID: 305939 [TBL] [Abstract][Full Text] [Related]
38. Structural significance of the benzoyl group at the C-3'-N position of paclitaxel for nitric oxide and tumor necrosis factor production by murine macrophages. Kirikae T; Ojima I; Ma Z; Kirikae F; Hirai Y; Nakano M Biochem Biophys Res Commun; 1998 Apr; 245(3):698-704. PubMed ID: 9588177 [TBL] [Abstract][Full Text] [Related]
39. Altered maturation of dendritic cells by taxol, an anticancer drug. Joo HG J Vet Sci; 2003 Dec; 4(3):229-34. PubMed ID: 14685027 [TBL] [Abstract][Full Text] [Related]
40. Immune modulation by interleukin-12 in tumor-bearing mice receiving vitamin D3 treatments to block induction of immunosuppressive granulocyte/macrophage progenitor cells. Prechel MM; Lozano Y; Wright MA; Ihm J; Young MR Cancer Immunol Immunother; 1996 May; 42(4):213-20. PubMed ID: 8665568 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]